Astellas Pharma Inc. (OTCPK:ALPMF) This autumn 2024 Earnings Conference Identify April 25, 2025 4:00 AM ET
Agency People
Hiromitsu Ikeda – Chief Communications and IR Officer
Naoki Okamura – Advisor Director, President & Chief Govt Officer
Claus Zieler – Chief Industrial Officer & Medical Affairs Officer
Tadaaki Taniguchi – Chief Medical Officer
Atsushi Kitamura – Chief Financial Officer
Conference Identify People
Hidemaru Yamaguchi – Citigroup Securities
Seiji Wakao – JPMorgan Securities
Akinori Ueda – Goldman Sachs Securities
Shinichiro Muraoka – Morgan Stanley MUFG Securities
Hiroyuki Matsubara – Nomura Securities
Miki Sogi – Sanford C. Bernstein
Kazuaki Hashiguchi – Daiwa Securities
Fumiyoshi Sakai – UBS Securities
Hiromitsu Ikeda
Thanks very quite a bit for turning into a member of our FY 2024 Financial Outcomes Announcement Meeting by Astellas Pharma Inc. out of your very busy schedule instantly. I’m delighted to operate a moderator. I’m Ikeda, Chief Communications and IR Officer. Because of your time.
Within the current day after presentation, we switch on to Q&A session. Presentation will most likely be made primarily based totally on the material posted on our site beneath the IR Meeting Half. We’ve received simultaneous translation between Japanese and English along with Q&A. We are able to’t guarantee the accuracy of the interpretation. Thanks for understanding. You probably can choose the language from the menu on the Zoom webinar show. In the event you select the distinctive language, it’s possible you’ll take heed to the distinctive sound with out going by the interpretation.
Disclaimer for instantly, this supplies or illustration by representatives for the company, and their options and assertion throughout the Q&A session accommodates forward-looking statements primarily based totally on assumptions and beliefs in delicate of the info in the meanwhile accessible to administration and subject to vital risks and uncertainties. Exact financial outcomes might differ materially counting on fairly just a few parts. They comprise data on pharmaceuticals, along with compounds beneath enchancment, nonetheless this data shouldn’t be speculated to make any representations or adverts
Supply hyperlink
